Targeted Therapies in Small Cell Lung Cancer: From Old Failures to Novel Therapeutic Strategies

The clinical management of small cell lung cancer (SCLC) treatment remains a major challenge for thoracic oncologists, with very few therapeutic advances significantly impacting patients’ survival. The recent introduction of immunotherapy in the clinical setting produced a marginal benefit for a lim...

Descripción completa

Detalles Bibliográficos
Autores principales: Cani, Massimiliano, Napoli, Valerio Maria, Garbo, Edoardo, Ferrari, Giorgia, Del Rio, Benedetta, Novello, Silvia, Passiglia, Francesco
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10218846/
https://www.ncbi.nlm.nih.gov/pubmed/37240229
http://dx.doi.org/10.3390/ijms24108883

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10218846/
https://www.ncbi.nlm.nih.gov/pubmed/37240229
http://dx.doi.org/10.3390/ijms24108883

Ejemplares similares